KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $305.2 million.

  • Vir Biotechnology's Change in Acquisitions & Divestments fell 1558.31% to $305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 4615.08%. This contributed to the annual value of $1.7 billion for FY2024, which is 2105.69% down from last year.
  • Vir Biotechnology's Change in Acquisitions & Divestments amounted to $305.2 million in Q3 2025, which was down 1558.31% from $251.3 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Change in Acquisitions & Divestments ranged from a high of $715.7 million in Q4 2023 and a low of $79.9 million during Q3 2021
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $303.5 million (2025), whereas its average is $340.8 million.
  • Per our database at Business Quant, Vir Biotechnology's Change in Acquisitions & Divestments surged by 42768.87% in 2023 and then tumbled by 5792.51% in 2024.
  • Vir Biotechnology's Change in Acquisitions & Divestments (Quarter) stood at $79.9 million in 2021, then skyrocketed by 233.92% to $266.7 million in 2022, then skyrocketed by 168.39% to $715.7 million in 2023, then plummeted by 57.93% to $301.1 million in 2024, then grew by 1.34% to $305.2 million in 2025.
  • Its last three reported values are $305.2 million in Q3 2025, $251.3 million for Q2 2025, and $301.9 million during Q1 2025.